Hunterdon Medical Center has received the American Heart Association/American Stroke Association’s Get With The Guidelines-Stroke Gold Plus and Target: Stroke Honor Roll Elite Quality Achievement Award.
The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
Hunterdon Medical Center earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.
Hunterdon Medical Center additionally received the association’s Target: Stroke Honor Roll Elite award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPa, the only drug approved by the U.S. Food and Drug Administration to treat Ischemic Stroke.
Hunterdon Medical Center has also met specific scientific guidelines as a Primary Stroke Center, featuring a comprehensive system for rapid diagnosis and treatment of stroke patients admitted to the emergency department.